Literatura académica sobre el tema "IGFBP1"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "IGFBP1".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "IGFBP1"
Czogała, Wojciech, Wojciech Strojny, Przemysław Tomasik, Mirosław Bik Multanowski, Małgorzata Wójcik, Klaudia Miklusiak, Emil Krzysztofik, Albert Wróbel, Karol Miklusiak y Szymon Skoczeń. "The Insight into Insulin-Like Growth Factors and Insulin-Like Growth-Factor-Binding Proteins and Metabolic Profile in Pediatric Obesity". Nutrients 13, n.º 7 (15 de julio de 2021): 2432. http://dx.doi.org/10.3390/nu13072432.
Texto completoZhong, Zhenglan, Xiaoping Xu, Shiguo Han, Yongxiang Shao y Yong Yi. "Comprehensive Analysis of Prognostic Value and Immune Infiltration of IGFBP Family Members in Glioblastoma". Journal of Healthcare Engineering 2022 (4 de julio de 2022): 1–13. http://dx.doi.org/10.1155/2022/2929695.
Texto completoZheng, Ruoyi, Wenming Chen, Weiting Xia, Jingyu Zheng y Qing Zhou. "The Prognostic Values of the Insulin-Like Growth Factor Binding Protein Family in Ovarian Cancer". BioMed Research International 2020 (16 de noviembre de 2020): 1–15. http://dx.doi.org/10.1155/2020/7658782.
Texto completoMinchenko, Dmytro O., D. O. Tsymbal, O. P. Yavorovsky, N. V. Solokha y O. H. Minchenko. "Expression of genes encoding IGFBPs, SNARK, CD36, and PECAM1 in the liver of mice treated with chromium disilicide and titanium nitride nanoparticles". Endocrine Regulations 51, n.º 2 (25 de abril de 2017): 84–95. http://dx.doi.org/10.1515/enr-2017-0008.
Texto completoRehman, Muhammad Saif-ur, Muqeet Mushtaq, Faiz-ul Hassan, Zia-ur Rehman, Muhammad Mushahid y Borhan Shokrollahi. "Comparative Genomic Characterization of Insulin-Like Growth Factor Binding Proteins in Cattle and Buffalo". BioMed Research International 2022 (25 de julio de 2022): 1–15. http://dx.doi.org/10.1155/2022/5893825.
Texto completoSimmons, Rebecca M., David W. Erikson, Jinyoung Kim, Robert C. Burghardt, Fuller W. Bazer, Greg A. Johnson y Thomas E. Spencer. "Insulin-Like Growth Factor Binding Protein-1 in the Ruminant Uterus: Potential Endometrial Marker and Regulator of Conceptus Elongation". Endocrinology 150, n.º 9 (4 de junio de 2009): 4295–305. http://dx.doi.org/10.1210/en.2009-0060.
Texto completoFouque, D., Y. Le Bouc, M. Laville, F. Combarnous, M. O. Joly, P. Raton y P. Zech. "Insulin-like growth factor-1 and its binding proteins during a low-protein diet in chronic renal failure." Journal of the American Society of Nephrology 6, n.º 5 (noviembre de 1995): 1427–33. http://dx.doi.org/10.1681/asn.v651427.
Texto completoAlterki, Abdulmohsen, Eman Al Shawaf, Irina Al-Khairi, Preethi Cherian, Devarajan Sriraman, Maha Hammad, Thangavel A. Thanaraj et al. "The Rise of IGFBP4 in People with Obstructive Sleep Apnea and Multilevel Sleep Surgery Recovers Its Basal Levels". Disease Markers 2021 (4 de octubre de 2021): 1–9. http://dx.doi.org/10.1155/2021/1219593.
Texto completoAlterki, Abdulmohsen, Eman Al Shawaf, Irina Al-Khairi, Preethi Cherian, Devarajan Sriraman, Maha Hammad, Thangavel A. Thanaraj et al. "The Rise of IGFBP4 in People with Obstructive Sleep Apnea and Multilevel Sleep Surgery Recovers Its Basal Levels". Disease Markers 2021 (4 de octubre de 2021): 1–9. http://dx.doi.org/10.1155/2021/1219593.
Texto completoKharkova, A., D. Minchenko, D. Tsymbal y O. Minchenko. "Expression of IGFBP1, IGFBP2 and IGF2BP3 genes in U87 glioma cells with suppressed ERN1 signaling enzyme function in glutamine and glucose deprivation conditions". Bulletin of Taras Shevchenko National University of Kyiv. Series: Biology 68, n.º 3 (2014): 24–29. http://dx.doi.org/10.17721/1728_2748.2014.68.24-29.
Texto completoTesis sobre el tema "IGFBP1"
Matz-Soja, Madlen y Rolf Gebhardt. "Hepatic Hedgehog signaling contributes to the regulation of IGF1 and IGFBP1 serum levels". Universitätsbibliothek Leipzig, 2014. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-142560.
Texto completoGreen, Charmaine. "THE ROLE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR SIGNALLING IN THE MOUSE EMBRYO DURING PREIMPLANTATION DEVELOPMENT AND EARLY IMPLANTATION". Thesis, The University of Sydney, 2016. http://hdl.handle.net/2123/17684.
Texto completoLin, Wan-Jung. "The nuclear actions of IGFBP-3". Online access for everyone, 2006. http://www.dissertations.wsu.edu/Thesis/Summer2006/w%5Flin%5F072606.pdf.
Texto completoEddiry, Sanaa. "Rôle du SNORD116 et de l'IGFBP7 dans la réponse à l'IGF1 dans le syndrome de Prader-Willi". Toulouse 3, 2013. http://www.theses.fr/2013TOU30215.
Texto completoPrader-willi syndrome (PWS) is a complex genetic disease of neurodevelopment that arises from lack of expression of paternally imprinted genes on chromosome 15q11-q13. GH levels are low in PWS, and GH treatment is recommended. The current management of PWS patients includes early treatment by growth hormone (GH). We demonstrated that GH treatment of PWS patients is associated with elevated IGF1 levels. Human chromosome 15q11-q13 contains an imprinting control region, which when deleted is sufficient to cause PWS. In addition, human genetic studies have defined a minimal PWS gene locus including a cluster of paternally expressed small nucleolar RNA (snoRNA), within the SNORD116. This makes PWS the first human disease found to be caused by loss of non-coding RNA. Our results showed increased sensitivity to IGF1 and Insulin in PWS cells. These cells demonstrate also increased proliferation rate and decreased senescence. From multi-array and RT-qPCR analysis, expression of IGFBP7, an important antiproliferative factor, was dramatically decreased in those patients. IGFBP7 is known to interact with IGF1 and Insulin receptors to decrease their action. We demonstrated that the lack of expression of SNORD116 in this patient results in increased response to IGF1 and Insulin and highly decreased secretion of IGFBP7. Therefore lack of SNORD116 results in high proliferation rate and decreased senescence in PWS, with decreased IGFBP7 secretion. Finally, we found that the increase of IGF1 level was significantly correlated with the decrease of IGFBP7 level in the serum of PWS children treated one year with GH. These data suggest that the lack of SNORD116 expression results in increased responsiveness to growth factors due to a low level of IGFBP7 in cells of PWS patients. They highlight a new phenotype of PWS, modified IGFBP7 levels, which, given the properties of IGFBP7 as a strong regulator of IGF1 effect, has potential consequences on the management of PWS patients treated by GH
Grosse, Christina Maria. "Knochenalterassozierte IGF-I und IGFBP-3 Befunde". Diss., lmu, 2008. http://nbn-resolving.de/urn:nbn:de:bvb:19-93014.
Texto completoHO, Penny Pei-Ying. "NOVEL IGF-INDEPENDENT MECHANISMS OF IGFBP-5". Thesis, The University of Sydney, 2013. http://hdl.handle.net/2123/10010.
Texto completoTROTTA, ROSA. "A novel biomarker for cancer and autoimmune diseases: IGFBP6". Doctoral thesis, Università degli Studi di Foggia, 2019. http://hdl.handle.net/11369/382356.
Texto completoBody temperature is an important defense mechanism and is the result of a complex interaction of many factors. In healthy human, the body temperature is regulated very carefully; deviations of 0.5°C above the upper limit of normal are considered to be significant indications of disease. Numerous elements may induce febrile conditions, including acute heart failure/stress cardiomyopathy [1] and acute myocardial infarction [2] neuroleptic malignant syndrome [3], endocrinopathies [4, 5], central nervous system (CNS) disorders [6] and oncological diseases [7]. Febrile temperatures increase the effectiveness of the immune response during infections by stimulating both the innate and adaptive arms of the immune system. The aim of this study is to demonstrate how hyperthermia can induce changes in the gene expression profile and highlight new early markers of prognosis/diagnosis in autoimmune and/or tumor pathologies. Among the up-regulated genes in dendritic cells, some encode secreted proteins, such as IGFBP6 [8]. This protein may have a functional role in the hyperthermic conditions as chemoattractant factor in monocytes and T cells, but not in B cells. Moreover, IGFBP6 is a selective neutrophil agonist, increasing oxidative burst and degranulation, as well as functioning as a chemotactic factor.
Pillai, Chitra Claire. "IGFPBp1 : a multifunctional role in implantation, embryonic and fetal development". Thesis, King's College London (University of London), 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.271064.
Texto completoPaula, Mariana Teresa Alves Sarti de. "Estudo da expressão do IGF1R mRNA em meninas com puberdade precoce central antes e durante o tratamento com análogos do GnRH". Universidade de São Paulo, 2015. http://www.teses.usp.br/teses/disponiveis/17/17144/tde-20072016-142344/.
Texto completoBACKGROUND: Growth spurt is a major event in central precocious puberty (CPP). GnRH analogues (GnRHa) treatment inhibit gonadal axis and decrease height velocity. However, serum IGF-I and IGFBP-3 remain high as before treatment. No reports regarding IGF type 1 receptor (IGF1R) in CPP is available. Considering that this could be a point of regulation of height velocity, the present study aims to study IGF1R mRNA expression in girls with CPP before and during GnRHa treatment. MÉTHODS: Sixteen girls with CPP (8.0±0.7yr) were evaluated before treatment (Group A) and sixteen (9.4±0.8yr) in use of GnRHa (Group B). Age-matched pre pubertal children were studied as controls (n=18). Fasting blood sample were collect for IGF1R mRNA expression analysis in peripheral lymphocytes (RT-PCR) and serum IGF-I, IGFBP-3, IGFBP-1 and insulin determination. RESULTS: The expression of IGF1R mRNA was higher in Group B than in Group A (p=0.04) and Controls (p=0.004). No difference was observed between Groups A and Controls. IGF-I, IGFBP-3 and IGF-I/IGFBP3 molar ratio were similar in Group A and B but higher than in Controls (p<0.0001). IGFBP-1 was higher (p<0.0001) in Controls than in Groups A and B. When we compare only Groups A and B, group B showed more IGFBP1 undetectable values than group A (p = 0.01) showing a tendency to lower values in group B. Insulin levels were lower in Controls than in Group A (p<0.001), but no difference were observed between Groups B and A. Negative correlation was found between insulin and IGFBP-1 when controls and Group A were put together (r= -0.5; p=0.007). This correlation disappear if Group B is included in the analysis. CONCLUSION: Serum concentrations of IGF-I, IGFBP-3, IGFBP-1 and insulin do not explain the decrease in height velocity during CPP treatment with GnRH analogue. The increase in IGF1R mRNA expression suggest impairment of IGF-I signaling and compensatory up regulation of the IGF1R. Increased GH concentrations due to reduction of IGF-I feedback could explain the IGF-I, IGFBP-3 and IGFBP-1 findings. Other studies are necessary to confirm this hypothesis by studying different signaling points in post-receptor cascade
Wilhelm, Franziska Katharina. "Der PI3K/AKT/mTOR-Signalweg und die Produktion des Insulinähnlichen Wachstumsfaktorbindungsproteins-2 (IGFBP-2) in humanen Adipozyten". Doctoral thesis, Universitätsbibliothek Leipzig, 2017. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-219991.
Texto completoLibros sobre el tema "IGFBP1"
Lai, Joe Heng. A polymorphic locus in the promoter region of the IGFBP3 gene is associated with mammographic breast density. Ottawa: National Library of Canada, 2003.
Buscar texto completoRauschnabel, Uta. RGD-spezifische Bindung von Insulin-ähnlichen Wachstumsfaktor Bindungsprotein 2 (IGFBP-2) an [alpha]5[beta]1-Integrinrezeptoren [alpha beta-Integrinrezeptoren] auf der Oberfläche von Ewingsarkom Zellen und IGF-unabhängige Effekte. Stuttgart, Augustenstr. 97: U. Rauschnabel, 2000.
Buscar texto completoHoeflich, Andreas, John Pintar y Briony Forbes, eds. Current Perspectives on Insulin-like Growth Factor Binding Protein (IGFBP) Research. Frontiers Media SA, 2019. http://dx.doi.org/10.3389/978-2-88945-718-2.
Texto completoPerks, Claire y Shin-Ichiro Takahashi, eds. The Role of the IGF/Insulin-IGFBP Axis in Normal Physiology and Disease. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-142-5.
Texto completoF. Moosavinasab, J. Ghiasi Ghalehkand, O. Ghanbari y S. Hassanpour. In ovo injection of IGF1 improves intestinal enzyme activity in broilers. Verlag Eugen Ulmer, 2015. http://dx.doi.org/10.1399/eps.2015.94.
Texto completoCapítulos de libros sobre el tema "IGFBP1"
van Roy, Frans, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis et al. "CCN3: NOV, IGFBP9, IGFBP-rP3". En Encyclopedia of Signaling Molecules, 282. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-0461-4_100183.
Texto completovan Roy, Frans, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis et al. "CCN1: Cyr61, CEF10, ßIG-M1, IGFBP10, IGFBP-rP4". En Encyclopedia of Signaling Molecules, 282. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-0461-4_100181.
Texto completovan Roy, Frans, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis et al. "CCN2: CTGF, FISP12, HCS24, ßIG-M2, HBGF-0.8, Ecogenin, IGFBP8, IGFBP-rP2". En Encyclopedia of Signaling Molecules, 282. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-0461-4_100182.
Texto completoFang, Peng, Vivian Hwa y Ron Rosenfeld. "IGFBPs and Cancer". En Biology of IGF-1: Its Interaction with Insulin in Health and Malignant States, 215–34. Chichester, UK: John Wiley & Sons, Ltd, 2008. http://dx.doi.org/10.1002/0470869976.ch14.
Texto completoSavage, M. O., J. C. Blair, A. J. Jorge, M. E. Street, M. B. Ranke y C. Camacho-Hübner. "IGFs and IGFBPs in GH Insensitivity". En IGF-I and IGF Binding Proteins, 100–106. Basel: KARGER, 2005. http://dx.doi.org/10.1159/000085760.
Texto completoPowell, David R., Phillip D. K. Lee y Adisak Suwanichkul. "Multihormonal Regulation of IGFBP-1 Promoter Activity". En Advances in Experimental Medicine and Biology, 205–14. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-2988-0_20.
Texto completoAimaretti, Gianluca, Roberto Baldelli, Ginevra Corneli, Chiara Croce,, Silvia Rovere, Claudia Baffoni, Simonetta Bellone et al. "IGFs and IGFBPs in Adult Growth Hormone Deficiency". En IGF-I and IGF Binding Proteins, 76–88. Basel: KARGER, 2005. http://dx.doi.org/10.1159/000085758.
Texto completoHuynh, HoangDinh, Megan Kaba, Sonali Rudra, Junke Zheng, Catherine J. Wu, Harvey F. Lodish y Cheng Cheng Zhang. "IGFBP2 Supports ex vivo Expansion of Hematopoietic Stem Cells". En Research and Perspectives in Endocrine Interactions, 21–41. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-642-04302-4_3.
Texto completoHolly, Jeff M. P. y Janet K. Fernihough. "The Insulin-Like Growth Factor (IGF) Binding Proteins (IGFBPS)". En Growth Hormone, 77–96. Boston, MA: Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-5163-8_5.
Texto completoMesotten, Dieter y Greet Van den Berghe. "Changes Within the GH/IGF-I/IGFBP Axis in Critical Illness". En Acute Endocrinology, 181–98. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-60327-177-6_9.
Texto completoActas de conferencias sobre el tema "IGFBP1"
Slater, Tom, Alexander-Francisco Bruns y Stephen Wheatcroft. "117 The divergent effects of IGFBP1 and IGFBP2 on vascular endothelial function". En British Cardiovascular Society Annual Conference ‘High Performing Teams’, 4–6 June 2018, Manchester, UK. BMJ Publishing Group Ltd and British Cardiovascular Society, 2018. http://dx.doi.org/10.1136/heartjnl-2018-bcs.116.
Texto completoLeRoy, Elizabeth C., Elizabeth T. Jacobs, Erin L. Ashbeck, María Elena Martínez, Loic Le Marchand, Peter Lance, David Duggan y Patricia A. Thompson. "Abstract 2853: Genetic variation in IGF1, GHR, and IGFBP1 is associated with colorectal cancer". En Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-2853.
Texto completoKim, Jin Cheon, Ye Jin Ha, Ka Hee Tak, Seon Ae Roh, Chan Wook Kim, Tae Won Kim, Dong-Hyung Cho, Seon-Kyu Kim, Seon-Young Kim y Yong Sung Kim. "Abstract 1641: Complex behavior of ALDH1A1 and IGFBP1 in liver metastasis of colorectal cancer". En Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-1641.
Texto completoUngurs, O., M. Vetter, N. Pazaitis, J. Beer, C. Thomssen y C. Wickenhauser. "Expression von IGF2BP1 in Ovarialkarzinomen". En 12. Jahrestagung der Mitteldeutschen Gesellschaft für Frauenheilkunde und Geburtshilfe e.V. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1645902.
Texto completoBacku, E., E. Aschenbrenner, K. Pollinger, S. Schlosser, K. Gülow, C. Kunst y M. Müller-Schilling. "Relevanz von IGFBP2 im hepatozellulären Karzinom". En Viszeralmedizin 2019. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1695235.
Texto completoAhasic, Amy M., Rihong Zhai, Li Su, Konstantinos Aronis, Christos S. Mantzoros, B. T. Thompson y David C. Christiani. "IGFBP3 Polymorphism Is Associated With Plasma Insulin-Like Growth Factor (IGF)-1 And Insulin-Like Growth Factor Binding Protein (IGFBP-3) In An Intensive Care Unit (ICU) Cohort". En American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a3545.
Texto completoLohse, M., D. Gschwind, E. Aschenbrenner, K. Pollinger, S. Schlosser, C. Kunst y M. Müller-Schilling. "Die p53-Familie reguliert IGFBP2 beim hepatozellulären Karzinom". En Viszeralmedizin 2017. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1605129.
Texto completoFathy, A., M. Habeb, S. Embarak, M. M. Zalat y N. A. A. Oweedah. "Non-Invasive IGFBP 1 and IGFBP 2 Biomarkers as Predictors of Therapy and Outcomes in Usual Interstitial Pneumonia". En American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3079.
Texto completoGuiot, Julien, Monique Henket, Jean-Louis Corhay y Renaud Louis. "Serum IGFBP2 as a marker of idiopathic pulmonary fibrosis". En Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa3840.
Texto completoKolligs, F., E. Backu, D. Gschwind, E. Aschenbrenner, K. Pollinger, K. Gülow, C. Kunst y M. Müller-Schilling. "Dosisabhängige Effekte von IGFBP2 auf die Viabilität von Hepatomzellen". En Viszeralmedizin 2021 Gemeinsame Jahrestagung Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), Sektion Endoskopie der DGVS, Deutsche Gesellschaft für Allgemein und Viszeralchirurgie (DGAV). Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1733618.
Texto completoInformes sobre el tema "IGFBP1"
Schoen, Timothy J. Expression and Characterization of Insulin-Like Growth Factor Binding Proteins (IGFBPs) and IGFBP-2 mRNA in the Developing Chicken Eye. Fort Belvoir, VA: Defense Technical Information Center, marzo de 1995. http://dx.doi.org/10.21236/ad1011459.
Texto completoFunkenstein, Bruria y Cunming Duan. GH-IGF Axis in Sparus aurata: Possible Applications to Genetic Selection. United States Department of Agriculture, noviembre de 2000. http://dx.doi.org/10.32747/2000.7580665.bard.
Texto completoYee, Douglas A. Prevention of Breast Cancer by IGFBP. Fort Belvoir, VA: Defense Technical Information Center, junio de 2002. http://dx.doi.org/10.21236/ada405491.
Texto completoYee, Douglas A. Prevention of Breast Cancer in IGFBP. Fort Belvoir, VA: Defense Technical Information Center, junio de 2004. http://dx.doi.org/10.21236/ada431788.
Texto completoYee, Douglas. Prevention of Breast Cancer in IGFBP. Fort Belvoir, VA: Defense Technical Information Center, junio de 2003. http://dx.doi.org/10.21236/ada421773.
Texto completoChen, Xiaole, Peng Wang, Yunquan Luo, Yi-Yu Lu, Wenjun Zhou, Mengdie Yang, Jian Chen, Zhi-Qiang Meng y Shi-Bing Su. Therapeutic Efficacy Evaluation and Underlying Mechanisms Prediction of Jianpi Liqi Decoction for Hepatocellular Carcinoma. Science Repository, septiembre de 2021. http://dx.doi.org/10.31487/j.jso.2021.02.04.sup.
Texto completoCobb, Laura. Understanding the Apoptotic Functions of IGFBP-3 in Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, noviembre de 2007. http://dx.doi.org/10.21236/ada593327.
Texto completoCobb, Laura y Pinchas Cohen. Understanding the Apoptotic Functions of IGFBP-3 in Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, noviembre de 2006. http://dx.doi.org/10.21236/ada464008.
Texto completoOh, Youngman. Role of IGFBP-3/IGFBP-3 Receptor Interaction in Normal and Malignant Mammary Growth: A Potential Diagnostic Parameter and New Strategy for Endocrine Therapy. Fort Belvoir, VA: Defense Technical Information Center, septiembre de 2000. http://dx.doi.org/10.21236/ada392333.
Texto completoZhang, Wei. The Cellular Localization of IGFBP5 Determines its Oncogenic Functions in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, agosto de 2006. http://dx.doi.org/10.21236/ada457676.
Texto completo